Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kirsch

Showing results (351-360 of 376) with videos related to

Pageof 38
Sort By:
Cancer Research|July 5, 2006
Gene expression differences in normal esophageal mucosa associated with regression and progression of mild and moderate squamous dysplasia in a high-risk Chinese populationNina Joshi, Laura Lee Johnson, Wen-Qiang Wei, et al.
Oncogene|April 27, 2004
Sil overexpression in lung cancer characterizes tumors with increased mitotic activityAyelet Erez, Marina Perelman, Stephen M Hewitt, et al.
Blood Cancer Discovery|May 15, 2024
Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor-Adoptive T-cell TherapyGeorge Mo, Sang Y Lee, David G Coffey, et al.
Cancer Research|March 5, 2003
Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mappingWilliam C Reinhold, Hosein Kouros-Mehr, Kurt W Kohn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 13, 2006
Celecoxib treatment alters the gene expression profile of normal colonic mucosaOleg K Glebov, Luz M Rodriguez, Patrick Lynch, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 5, 2020
Correction to: Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learningJ M Bokhorst, A Blank, A Lugli, et al.
Blood|August 1, 2015
Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphomaAlain H Rook, Joel M Gelfand, Joel C Gelfand, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 18, 2019
Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learningJ M Bokhorst, A Blank, A Lugli, et al.
Science Translational Medicine|October 12, 2022
Minimally invasive, sustained-release relaxin-2 microparticles reverse arthrofibrosisJack R Kirsch, Amanda K Williamson, Diana Yeritsyan, et al.
Blood Cancer Journal|March 6, 2023
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patientsRodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, et al.
Pageof 38

Showing results (351-360 of 376) with videos related to

Sort By:
Pageof 38
Cancer Research|July 5, 2006
Gene expression differences in normal esophageal mucosa associated with regression and progression of mild and moderate squamous dysplasia in a high-risk Chinese populationNina Joshi, Laura Lee Johnson, Wen-Qiang Wei, et al.
Oncogene|April 27, 2004
Sil overexpression in lung cancer characterizes tumors with increased mitotic activityAyelet Erez, Marina Perelman, Stephen M Hewitt, et al.
Blood Cancer Discovery|May 15, 2024
Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor-Adoptive T-cell TherapyGeorge Mo, Sang Y Lee, David G Coffey, et al.
Cancer Research|March 5, 2003
Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mappingWilliam C Reinhold, Hosein Kouros-Mehr, Kurt W Kohn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 13, 2006
Celecoxib treatment alters the gene expression profile of normal colonic mucosaOleg K Glebov, Luz M Rodriguez, Patrick Lynch, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 5, 2020
Correction to: Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learningJ M Bokhorst, A Blank, A Lugli, et al.
Blood|August 1, 2015
Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphomaAlain H Rook, Joel M Gelfand, Joel C Gelfand, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 18, 2019
Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learningJ M Bokhorst, A Blank, A Lugli, et al.
Science Translational Medicine|October 12, 2022
Minimally invasive, sustained-release relaxin-2 microparticles reverse arthrofibrosisJack R Kirsch, Amanda K Williamson, Diana Yeritsyan, et al.
Blood Cancer Journal|March 6, 2023
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patientsRodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, et al.
Pageof 38